MindMed has dosed the first subject in the Phase III Panorama study of MM120 ODT for the treatment of generalised anxiety ...

MSD said that its sotatercept steering committee called for the trial to end as patients are moved to the ongoing open-label ...

The EMA has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer trial in Europe to add 11 new sites.

MM PD market growth will be driven by advancements in innovative therapies, including the first DMTs, and a growing patient ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

The US Food and Drug Administration has released draft guidance on protocol deviations, but experts say it could go further.

The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his ...

Kashiv Biosciences has reported that a trial of its 125mg/mL pre-filled syringe injection, KSHB002, has achieved its primary ...

Imvax has secured $29m in a financing round from current investors, aimed at advancing the Phase IIb trial of IGV-001, in ndGBM individuals.

Ryght AI has partnered with Cancer Research South Australia (CRSA) to advance cancer clinical trials and expand patient ...

The Phase III trial saw a clinically meaningful benefit in overall survival with a combination of Itovebi alongside Ibrance ...

Akero Therapeutics has revealed preliminary outcomes from its Phase IIb study of EFX in individuals with compensated ...